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Our research line focuses on the role that neurosteroids such as allopregnanolone 
(AlloP) play during brain maturation and the effects that the alterations of neonatal 
neurosteroids levels have on adolescent and adult behavior, and on hippocampal 
inhibitory mechanisms. We can resume our recent work in three main lines: 
1.-Alterations in neonatal AlloP levels affect adolescent and adult behavior, and this 
effect is related to neonatal stress: We have reported disruptions in prepulse inhibition 
(PPI), increases in novelty-directed locomotion measured in the open field test and 
decreases in anxiety-like responses in the elevated plus maze test. Some of the 
deleterious effects of neonatal stress (by means of early maternal separation -EMS-) 
can be prevented by previous neonatal AlloP administration. 
2.-Role of the hippocampus and the hippocampal inhibitory mechanisms: (a) 
Behavioral effects of intrahippocampal AlloP infusions in adult age (decrease in anxiety 
and locomotion or increase in PPI) are not present in those subjects in whom neonatal 
AlloP levels were altered. (b) Neonatal alteration of AlloP levels alters the expression of 
type A gamma-aminobutyric-acid receptors (GABAA) containing α4 and δ subunits, 
molecular alterations that can persist into adult age and that can explain, in part, the 
reported behavioral disturbances.  
3.-Vulnerability to drug abuse: Sensation seeking patterns of behavior, impulsivity and 
novelty preference can increase the vulnerability to drug abuse in humans and animals. 
Given the anxiolytic-like profile and the increase in novel environments exploration 
caused by neonatal AlloP administration, we hypothesize that neonatal AlloP levels 
manipulations can alter the vulnerability to drug abuse. At present, we are investigating 
the effects of neonatal AlloP levels alteration alone or in combination with 
environmental stress (by EMS) on alcohol abuse throughout the study of voluntary 
alcohol intake, ethanol motor stimulant effects, dopamine levels in the nucleus 
accumbens, and monoamine levels in ventral striatum. 
 
